New PM will ‘inherit an NHS in its most challenging state for decades’
Warning comes from NHS leaders as new Prime Minister prepares to move into Number 10
Read More
Author: John Pinching
Sanofi and Regeneron’s Dupixent shows consistent safety profile
Study involving children aged six to 11 years with moderate-to-severe asthma reveals positive data
Read More
First patient enrolled in Modus’ sevuparin trial
Research is evaluating the therapy among paediatric patients with severe malaria
Read More
Green light for cancer drugs developed by AI specialist Owkin
AI company has its breast cancer and colorectal therapies approved for use in Europe
Read More
Avacta announces clinical study of AVA6000
Pro-doxorubicin will advance to the fourth dose following a positive review of safety and tolerability
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
